The US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target action date for ...
Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for ...
Immuron Limited announced the submission of the Clinical Study Report for its Phase 2 clinical trial of Travelan® (IMM-124E) to the FDA, which demonstrated statistically significant immunological and ...
Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb ...
• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...
A new clinical trial underway in the Lowcountry is drawing attention for its unconventional, and potentially groundbreaking, ...
A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Explore how AI can optimize study design, speed patient recruitment, and streamline operational workflows to shorten ...
The clinical trial industry is at a critical juncture where traditional methods are proving insufficient for managing today’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback